
Michael A. Morris
Physician-scientist and co-founder of United Theranostics, board-certified in diagnostic radiology, nuclear medicine, and clinical informatics, focused on community-based radiopharmaceutical therapy and theranostics.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
Aug 28, 2026
The New Chemist’s Podcasting Group: The Path to KOLs — Interview with Dr. Michael A. Morris, MD, MS, DABR, DABNM, DCI — Co-Founder, United Theranostics
11:21
11:28
11:32
11:52
12:01
12:06
12:23
34:49

David FergusonHOST
Um, what else would you say has contributed to you doing the work? What keeps you going in this field?

Michael A. MorrisGUEST
Yeah, you know, um, uh, there are so many patient examples that I've had.

Michael A. MorrisGUEST
One of the things that is, um, particularly impressive to me is, um, that oftentimes we see in the clinical trial results for radiopharmaceutical therapy that, um, some patients are able to have a complete response from these treatments, and that doesn't necessarily mean that their disease is cured.

Michael A. MorrisGUEST
Although in the case of thyroid cancers, um, it is pretty well understood that we can cure thyroid cancer with iodine one thirty-one, for instance.

Michael A. MorrisGUEST
That's the one that's been around for the longest, um, over eighty years now.

Michael A. MorrisGUEST
Um, and we have enough experience with it that we know how to use it very well, um, to really, uh, treat patients when they have metastatic disease, uh, to the-- even the lungs or the bone outside of the thyroid, um, or lymph nodes, and really, um, have them not have recurrence.

Michael A. MorrisGUEST
I think for the other treatments like the, um, Pluvicto and Lutathera, which are newer, we, um- I, I think that we have more work to do, um, before we can really say that we can use them as effectively as iodine, which you have lots of experience with.
22 MINS LATER

David FergusonHOST
So on a lighter note, um, what advice would you give to someone who sees the work that you're doing and they're like, they are captivated and they want to pursue nuclear medicine? What advice would you give medical students and potentially pharmacy students or future clinicians who are interested in nuclear medicine? What advice would you give them? What do you think is a good mindset to have when entering and when operating in the field? And what has been some beneficial advice that you have received?